- Launch of Distribution of the OptiLight M22 IPL Model(PDF)
- Launch of Distribution of “Smart MIEr”(PDF)
- Senju initiated Phase III Clinical Trials in Japan for “SJP-0132” for the treatment of Dry Eye Disease. The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju(PDF)
- Announcement of collaboration agreement with Alchemedicine, Inc.(PDF)
- Launch of Distribution of “MIEr-Blue” and “MIEr-Red”(PDF)
- Launch and Distribution of “Soft-MIEr” and “MIEr for Claio”(PDF)
- Announcement of Strategic Capital and Business Alliance(PDF)
- Launch of Distribution of the MIEr(PDF)
- Launch of Cloud Imaging Service (MIEr-CIS)(PDF)
- Announcement of Comprehensive Business Alliance(PDF)
- Launch of Distribution of GAP and GAP-screener- the Gaze Analyzing Perimeters(PDF)
- Launch of Distribution of the M22 IPL Model(PDF)
- Launch of Distribution of Medical Devices(PDF)